Advarsler om risikoen for myopati, herunder rabdomyolyse, samt advarsler om interaktion med gemfibrozil har været inkluderet i produktinformationen, siden der blev givet licens til Lipobay i EU.
Warnings about the risk of myopathy, including rhabdomyolysis, as well as warnings about the interaction with gemfibrozil have been included in product information since Lipobay was first licensed in the EU.